Investigation: FDA allows drugs without proven clinical benefit to languish for years on accelerated pathway.

FDA allows drugs without proven clinical benefit to languish for years on accelerated pathway – The BMJ

News release: Investigation finds nearly half of drugs granted FDA ‘fast track’ approval lack proven clinical benefit – The BMJ

Commentary: Over 100 Drugs Given Speedy Approvals Still Lack Proof of Clinical Efficacy – MedPage Today (free registration required)